Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01001819 · ClinicalTrials.gov registry record

DNA Microarray Analysis of Gene Expression in Chronic Rhinosinusitis

A clinical trial, sponsored by Montefiore Medical Center.

Completed
Registry status
30
Enrollment target

NCT01001819: Completed study, sponsored by Montefiore Medical Center.

NCT01001819 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01001819 has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

Analysis of differential gene expression in patients with chronic rhinosinusitis without polyps compared to unaffected patients. Correlation of abnormal gene expression with surgical outcomes.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2005-03
Est. Completion 2008-11-18
Montefiore Medical Center

345 total trials

What the finished NCT01001819 record still lists

NCT01001819 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01001819 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01001819 about?

NCT01001819 is a clinical study titled "DNA Microarray Analysis of Gene Expression in Chronic Rhinosinusitis". Analysis of differential gene expression in patients with chronic rhinosinusitis without polyps compared to unaffected patients. Correlation of abnormal gene expression with surgical outcomes.

What is the current status of trial NCT01001819?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-03. Estimated completion is 2008-11-18.

Who is sponsoring clinical trial NCT01001819?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01001819, the US trial registry maintained by the National Library of Medicine. NCT01001819 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.